Allianz Asset Management’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2014
Q3 | – | Sell |
-581,489
| Closed | -$21.2M | – | 1956 |
|
|
2014
Q2 | $21.2M | Sell |
581,489
-166,582
| -22% | -$6.08M | 0.03% | 538 |
|
|
2014
Q1 | $34.3M | Sell |
748,071
-24,354
| -3% | -$1.12M | 0.04% | 416 |
|
|
2013
Q4 | $30M | Buy |
772,425
+6,390
| +0.8% | +$249K | 0.04% | 446 |
|
|
2013
Q3 | $34.7M | Buy |
766,035
+55,315
| +8% | +$2.51M | 0.05% | 400 |
|
|
2013
Q2 | $34.9M | Buy |
+710,720
| New | +$34.9M | 0.05% | 383 |
|